Dexamethasone Sodium Phosphate NDC 85766-269

NDC codes

FDA NDC Directory

Product NDC (as listed)85766-269Labeler and product segments. Claims need a package NDC.

Product NDC at billing width85766-0269Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
85766-269-30	85766026930	1 VIAL, MULTI-DOSE in 1 BOX (85766-269-30) / 30 mL in 1 VIAL, MULTI-DOSEMarketed from Aug 31, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dexamethasone Sodium Phosphate
Generic name (nonproprietary): dexamethasone sodium phosphate
Active ingredients: Dexamethasone sodium phosphate — 4 mg/mL
Dosage form: Injection, Solution
Route: Intramuscular, Intravenous
Labeler: Sportpharm LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 084916
Marketing start: Sep 7, 2000
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 85766-269_5a564653-408d-0b7f-e063-6294a90a1898SPL ID 5a564653-408d-0b7f-e063-6294a90a1898SPL set ID 9822a5c3-d3f1-4e0b-9963-32b22740e10eRxCUI 1116927UNII AI9376Y64P
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N485766026930 followed by a unit qualifier and the quantity

Package 85766-0269-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 31, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE: Intravenous or Intramuscular Injection When oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, those products labeled for intravenous or intramuscular use are indicated as follows: • Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance) Acute adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; mineral…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 084916

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 084916
Product	Strength	Form · route	Labeler	Product NDC
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 4 mg/mL	Injection, SolutionIntramuscular, Intravenous	Cardinal Health 107, LLC	55154-9364
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 4 mg/mL	Injection, SolutionIntramuscular, Intravenous	Phlow Corporation	81565-202
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 4 mg/mL	Injection, SolutionIntramuscular, Intravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1370
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 4 mg/mL	Injection, SolutionIntramuscular, Intravenous	Fresenius Kabi USA, LLC	63323-165
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 4 mg/mL	Injection, SolutionIntramuscular, Intravenous	Fresenius Kabi USA, LLC	63323-165
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 4 mg/mL	Injection, SolutionIntramuscular, Intravenous	A-S Medication Solutions	50090-0414